Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Net Asset Momentum
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) recorded a net asset momentum of 3.1% as of December 2024, with net assets of CN¥1.82 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Hunan Warrant Pharmaceutical Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hunan Warrant Pharmaceutical Co. Ltd. A Net Asset Momentum (2019–2024)
This chart tracks Hunan Warrant Pharmaceutical Co. Ltd. A's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is +3.1%, with net assets of CN¥1.82 Billion CNY as of December 2024. Read Hunan Warrant Pharmaceutical Co. Ltd. A debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
The table below shows the complete annual net asset history for Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 688799 market cap overview.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.82 Billion | CN¥2.46 Billion | CN¥637.06 Million | ▲ +3.1% |
| 2023 | CN¥1.77 Billion | CN¥2.18 Billion | CN¥408.70 Million | ▲ +6.6% |
| 2022 | CN¥1.66 Billion | CN¥2.01 Billion | CN¥350.35 Million | ▲ +12.1% |
| 2021 | CN¥1.48 Billion | CN¥1.80 Billion | CN¥318.07 Million | ▲ +123.1% |
| 2020 | CN¥663.05 Million | CN¥921.12 Million | CN¥258.07 Million | ▲ +19.9% |
| 2019 | CN¥553.17 Million | CN¥851.44 Million | CN¥298.27 Million | — |